| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | C O Tacket | |
| P2860 | cites work | Antibody production by molecular farming in plants | Q30875986 |
| A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. | Q33181258 | ||
| Molecular farming of industrial proteins from transgenic maize. | Q33639683 | ||
| Food plant-delivered cholera toxin B subunit for vaccination and immunotolerization | Q33639691 | ||
| The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. | Q33914442 | ||
| Oral immunization with hepatitis B surface antigen expressed in transgenic plants | Q33944696 | ||
| Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA. | Q34001579 | ||
| Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants | Q34001658 | ||
| Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene | Q34067072 | ||
| Transgenic plants as factories for biopharmaceuticals | Q34076132 | ||
| Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit | Q34089082 | ||
| Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives | Q34171016 | ||
| Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants | Q34240349 | ||
| The regulation of biologic products derived from bioengineered plants | Q34280308 | ||
| Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine | Q34343918 | ||
| Producing proteins in transgenic plants and animals | Q34365219 | ||
| Transgenic plants as protein factories | Q34403818 | ||
| Immunogenicity of transgenic plant-derived hepatitis B surface antigen | Q34437147 | ||
| Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1. | Q34619929 | ||
| Appetising solutions: an edible vaccine for measles | Q34677625 | ||
| New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis. | Q34862961 | ||
| Oral immunogenicity of human papillomavirus-like particles expressed in potato | Q35182055 | ||
| Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain | Q35532132 | ||
| Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system | Q35553394 | ||
| Production of human papillomavirus type 16 virus-like particles in transgenic plants | Q35802720 | ||
| Immunization against rabies with plant-derived antigen | Q35922495 | ||
| Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations | Q37132203 | ||
| Expression of hepatitis B surface antigen in transgenic plants | Q37337644 | ||
| Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice | Q37584470 | ||
| Plant-derived immunocontraceptive vaccines | Q38479355 | ||
| Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants | Q39433548 | ||
| Basic processes underlying Agrobacterium-mediated DNA transfer to plant cells | Q39569880 | ||
| Transgenic plants as vaccine production systems | Q40405033 | ||
| Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. | Q40577761 | ||
| Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. | Q40613747 | ||
| Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers | Q40631622 | ||
| Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. | Q40688200 | ||
| Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form | Q40694013 | ||
| Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products | Q41819883 | ||
| Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg | Q41886182 | ||
| Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts | Q41947780 | ||
| Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine | Q44183728 | ||
| Norwalk virus genome cloning and characterization | Q44643083 | ||
| Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers | Q45711236 | ||
| Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutinin | Q45728664 | ||
| Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice. | Q45738399 | ||
| Human respiratory syncytial virus vaccine antigen produced in plants | Q45740005 | ||
| Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response | Q45740945 | ||
| Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes | Q45741675 | ||
| A plant-derived edible vaccine against hepatitis B virus. | Q45746962 | ||
| Recombinant Norwalk virus-like particles given orally to volunteers: phase I study | Q45748767 | ||
| Expression of the rabies virus glycoprotein in transgenic tomatoes | Q45755402 | ||
| A plant-based multicomponent vaccine protects mice from enteric diseases | Q45877640 | ||
| Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato | Q47614578 | ||
| Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground | Q47793719 | ||
| Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax. | Q54079999 | ||
| Expression of cholera toxin B subunit oligomers in transgenic potato plants. | Q54150448 | ||
| Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana. | Q54517140 | ||
| Delivery of subunit vaccines in maize seed. | Q54533764 | ||
| Oral immunization with a recombinant bacterial antigen produced in transgenic plants. | Q54612499 | ||
| Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans | Q55883944 | ||
| Phytosecretion of enteropathogenic Escherichia coli pilin subunit A in transgenic tobacco and its suitability for early life vaccinology | Q56762901 | ||
| Production of hepatitis B surface antigen in transgenic plants for oral immunization | Q57235165 | ||
| Economic evaluations applied to HB vaccination: general observations | Q57515369 | ||
| Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial | Q57926913 | ||
| The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens | Q71284362 | ||
| Generation and assembly of secretory antibodies in plants | Q72196270 | ||
| Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding | Q72363616 | ||
| Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants | Q73400096 | ||
| Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance | Q73486424 | ||
| Plant-based vaccines: unique advantages | Q73636886 | ||
| Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B | Q73636896 | ||
| The impact of foodborne calicivirus disease: the Minnesota experience | Q73770639 | ||
| Oral tolerance | Q74220407 | ||
| Production and purification of two recombinant proteins from transgenic corn | Q74297314 | ||
| Efficacy of a food plant-based oral cholera toxin B subunit vaccine | Q74401546 | ||
| Production of immunogenic VP6 protein of bovine group A rotavirus in transgenic potato plants | Q74446677 | ||
| Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle | Q74484602 | ||
| Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-mont | Q74519686 | ||
| Processing of transgenic corn seed and its effect on the recovery of recombinant beta-glucuronidase | Q74660385 | ||
| Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence | Q74733671 | ||
| Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen | Q77441971 | ||
| A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes | Q77683899 | ||
| Production of HIV-1 p24 protein in transgenic tobacco plants | Q77722747 | ||
| Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco | Q78171079 | ||
| Expression of cholera toxin B subunit in transgenic tomato plants | Q78529703 | ||
| A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT) | Q78529714 | ||
| Corn as a production system for human and animal vaccines | Q78805157 | ||
| Agrobiotechnology. Mixed message could prove costly for GM crops | Q79203377 | ||
| Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn | Q80842328 | ||
| P304 | page(s) | 103-117 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | Plant-based oral vaccines: results of human trials | |
| P478 | volume | 332 |
| Q35896237 | Combination vaccines against diarrheal diseases |
| Q38045834 | Construction and characterization of virus-like particles: a review |
| Q38307990 | Current status of viral expression systems in plants and perspectives for oral vaccines development |
| Q38796221 | Edible plants for oral delivery of biopharmaceuticals. |
| Q21089613 | Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells |
| Q38733265 | Expression of the VP40 antigen from the Zaire ebolavirus in tobacco plants. |
| Q28972559 | Immunology of Gut Mucosal Vaccines |
| Q39384289 | Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems |
| Q38727453 | Mucosal vaccine delivery: Current state and a pediatric perspective |
| Q90611943 | Oral edible plant vaccine containing hypoallergen of American cockroach major allergen Per a 2 prevents roach-allergic asthma in a murine model |
| Q59125274 | Plant-Based Vaccines: Production and Challenges |
| Q30386732 | Plant-made vaccines for humans and animals. |
| Q33878261 | Production of Recombinant Anti-Cancer Vaccines in Plants |
| Q37812659 | Strategies for the plant‐based expression of dengue subunit vaccines |
| Q43641692 | The mucosal immune response to plant-derived vaccines |
| Q37810695 | Vaccine production in plant systems — An aid to the control of viral diseases in domestic animals: A review |
| Q37752963 | Vaccines in veterinary medicine: a brief review of history and technology |
Search more.